IRD Company Profile and Key Details

NASDAQ : IRD

Opus Genetics

$6.04

-0.03-0.49%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Opus Genetics, Inc. (IRD) stock declined over -0.49%, trading at $6.04 on NASDAQ, down from the previous close of $6.07. The stock opened at $6.16, fluctuating between $5.77 and $6.58 in the recent session.

Stock Snapshot

6.07

Prev. Close

498.7M

Market Cap

5.77

Day Low

-4.72

P/E Ratio

-1.28

EPS (TTM)

N/A

Cash Flow per Share

6.16

Open

82.57M

Number of Shares

6.576

Day High

46.27%

Free Float in %

N/A

Book Value

4.65M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	6.16	6.58	5.77	6.04	4.65M
Sep 10, 2026	5.87	6.24	5.40	6.07	6.5M
Sep 09, 2026	5.31	7.07	5.31	5.73	53.79M
Sep 08, 2026	4.53	4.62	4.31	4.34	2.26M
Sep 04, 2026	4.53	4.80	4.40	4.67	2.24M
Sep 03, 2026	4.66	4.83	4.28	4.60	4.41M
Sep 02, 2026	3.86	4.52	3.86	4.45	4.99M
Sep 01, 2026	3.65	3.85	3.59	3.83	868.55K
Aug 31, 2026	3.71	3.72	3.51	3.62	575.1K
Aug 28, 2026	3.85	3.86	3.63	3.69	822.26K
Aug 27, 2026	3.80	3.92	3.79	3.85	545.57K
Aug 26, 2026	4.17	4.21	3.77	3.80	883.54K
Aug 25, 2026	4.07	4.42	4.04	4.11	1.5M
Aug 24, 2026	4.02	4.24	3.82	4.03	812.16K
Aug 21, 2026	4.16	4.33	4.02	4.05	1.05M
Aug 20, 2026	4.01	4.26	4.01	4.12	1.46M
Aug 19, 2026	3.76	4.08	3.76	4.07	730.95K
Aug 18, 2026	3.65	3.71	3.59	3.69	752.87K
Aug 17, 2026	3.60	3.75	3.55	3.65	608.37K
Aug 14, 2026	3.74	3.75	3.56	3.61	414.23K

Contact Details

Durham, NC 27713

United States

https://opusgtx.com 248 957 9024

About Company

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current Opus Genetics, Inc. (IRD) stock price?

Opus Genetics, Inc. (NASDAQ: IRD) stock price is $6.04 in the last trading session. During the trading session, IRD stock reached the peak price of $6.58 while $5.77 was the lowest point it dropped to. The percentage change in IRD stock occurred in the recent session was -0.49% while the dollar amount for the price change in IRD stock was - $0.03.

IRD's industry and sector of operation?

The NASDAQ listed IRD is part of Biotechnology industry that operates in the broader Healthcare sector. Opus Genetics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IRD?

No Data

How IRD did perform over past 52-week?

IRD's closing price is 347.41% higher than its 52-week low of $1.35 where as its distance from 52-week high of $7.07 is -14.57%.

How many employees does IRD have?

Number of IRD employees currently stands at 28.

Link for IRD official website?

Official Website of IRD is: https://opusgtx.com

How do I contact IRD?

IRD could be contacted at phone 248 957 9024 and can also be accessed through its website. IRD operates from 8 Davis Drive, Durham, NC 27713, United States.

How many shares of IRD are traded daily?

IRD stock volume for the day was 4.65M shares. The average number of IRD shares traded daily for last 3 months was 2.09M.

What is the market cap of IRD currently?

The market value of IRD currently stands at $498.70M with its latest stock price at $6.04 and 82.57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	28
Beta	0.58
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	28
Beta	0.58
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

IRD Company Profile and Key Details

Opus Genetics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Shareholding & Insider Activity

Financial & Profitability Overview

Earnings & Analyst Outlook

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Valuation Metrics